Issue Information ‐ Aims & Scope.
- Published in:
- Addiction, 2016, v. 111, n. 4, p. 570, doi. 10.1111/add.13111
- Publication type:
- Article
Works matching IS 09652140 AND DT 2016 AND VI 111 AND IP 4
Results: 35
1
2
Issue Information ‐ Title Page.
- Published in:
- Addiction, 2016, v. 111, n. 4, p. 569, doi. 10.1111/add.13110
- Publication type:
- Article
3
Issue Information ‐ TOC.
- Published in:
- Addiction, 2016, v. 111, n. 4, p. 760, doi. 10.1111/add.13109
- Publication type:
- Article
4
News and Notes.
- Published in:
- Addiction, 2016, v. 111, n. 4, p. 752, doi. 10.1111/add.13360
- Publication type:
- Article
5
New Books.
- Published in:
- 2016
- Publication type:
- Bibliography
6
NEW APPROVED NASAL NALOXONE WELCOME, BUT UNLICENSED IMPROVISED NALOXONE SPRAY KITS REMAIN A CONCERN: PROPER SCIENTIFIC STUDY MUST ACCOMPANY INNOVATION.
- Published in:
- Addiction, 2016, v. 111, n. 4, p. 590, doi. 10.1111/add.13319
- By:
- Publication type:
- Article
7
Commentary on Roberts et al. (2016): Bupropion and varenicline are efficacious and well-tolerated cessation medications for smokers with serious mental illness.
- Published in:
- 2016
- By:
- Publication type:
- Opinion
8
ENSURE GLOBAL ACCESS TO NALOXONE FOR OPIOID OVERDOSE MANAGEMENT.
- Published in:
- 2016
- By:
- Publication type:
- Opinion
9
Commentary on Imtiaz et al. (2016): The burden of disease attributable to cannabis--implications for policy.
- Published in:
- 2016
- By:
- Publication type:
- Opinion
10
ETHICAL ISSUES AND STAKEHOLDERS MATTER.
- Published in:
- 2016
- By:
- Publication type:
- Opinion
11
IS CAPTAGON (FENETHYLLINE) HELPING TO FUEL THE SYRIAN CONFLICT?
- Published in:
- 2016
- By:
- Publication type:
- Letter to the Editor
12
RADICAL RED TAPE REDUCTION BY GOVERNMENT SUPPORTED NASAL NALOXONE: THE NORWEGIAN PILOT PROJECT IS INNOVATIVE, SAFE AND AN IMPORTANT CONTRIBUTION TO FURTHER DEVELOPMENT AND DISSEMINATION OF TAKE-HOME NALOXONE.
- Published in:
- 2016
- By:
- Publication type:
- Opinion
13
INTRANASAL NALOXONE SOON TO BECOME PART OF EVOLVING CLINICAL PRACTICE AROUND OPIOID OVERDOSE PREVENTION.
- Published in:
- 2016
- By:
- Publication type:
- Opinion
14
The effect of potential electronic nicotine delivery system regulations on nicotine product selection.
- Published in:
- Addiction, 2016, v. 111, n. 4, p. 734, doi. 10.1111/add.13257
- By:
- Publication type:
- Article
15
Commentaries on Strang et al. (2016).
- Published in:
- 2016
- By:
- Publication type:
- Opinion
16
TOBACCO CONTROL RESEARCH: A TALE OF TWO DELPHI GROUPS.
- Published in:
- 2016
- By:
- Publication type:
- Letter to the Editor
17
LIQUOR LICENSING OR CONFOUNDING EVENTS? FURTHER QUESTIONS ABOUT THE INTERPRETATIONS OF MENÉNDEZ ET AL. (2015).
- Published in:
- 2016
- By:
- Publication type:
- Letter to the Editor
18
Population trends in smoking, alcohol use and primary prevention variables among adolescents in Iceland, 1997-2014.
- Published in:
- Addiction, 2016, v. 111, n. 4, p. 645, doi. 10.1111/add.13248
- By:
- Publication type:
- Article
19
Commentary on Ogeil et al. (2016): Explaining increased alcohol-related harm and stable per capita consumption in Australia.
- Published in:
- 2016
- By:
- Publication type:
- Opinion
20
Characteristics of users and usage of different types of electronic cigarettes: findings from an online survey.
- Published in:
- Addiction, 2016, v. 111, n. 4, p. 724, doi. 10.1111/add.13240
- By:
- Publication type:
- Article
21
Integrating smoking cessation into routine care in hospitals--a randomized controlled trial.
- Published in:
- Addiction, 2016, v. 111, n. 4, p. 714, doi. 10.1111/add.13239
- By:
- Publication type:
- Article
22
Long-term outcomes after randomization to buprenorphine/naloxone versus methadone in a multi-site trial.
- Published in:
- Addiction, 2016, v. 111, n. 4, p. 695, doi. 10.1111/add.13238
- By:
- Publication type:
- Article
23
The burden of disease attributable to cannabis use in Canada in 2012.
- Published in:
- Addiction, 2016, v. 111, n. 4, p. 653, doi. 10.1111/add.13237
- By:
- Publication type:
- Article
24
Efficacy and tolerability of pharmacotherapy for smoking cessation in adults with serious mental illness: a systematic review and network meta-analysis.
- Published in:
- Addiction, 2016, v. 111, n. 4, p. 599, doi. 10.1111/add.13236
- By:
- Publication type:
- Article
25
Respiratory sinus arrhythmia as a potential measure in substance use treatment--outcome studies.
- Published in:
- Addiction, 2016, v. 111, n. 4, p. 615, doi. 10.1111/add.13232
- By:
- Publication type:
- Article
26
Awareness and use of electronic cigarettes and heat-not-burn tobacco products in Japan.
- Published in:
- Addiction, 2016, v. 111, n. 4, p. 706, doi. 10.1111/add.13231
- By:
- Publication type:
- Article
27
Relation between age of first drinking and mental health and alcohol and drug disorders in adulthood: evidence from a 35-year cohort study.
- Published in:
- Addiction, 2016, v. 111, n. 4, p. 637, doi. 10.1111/add.13230
- By:
- Publication type:
- Article
28
Measuring benefits of opioid misuse treatment for economic evaluation: health-related quality of life of opioid-dependent individuals and their spouses as assessed by a sample of the US population.
- Published in:
- Addiction, 2016, v. 111, n. 4, p. 675, doi. 10.1111/add.13219
- By:
- Publication type:
- Article
29
Advancing patient-centered care for structurally vulnerable drug-using populations: a qualitative study of the perspectives of people who use drugs regarding the potential integration of harm reduction interventions into hospitals.
- Published in:
- Addiction, 2016, v. 111, n. 4, p. 685, doi. 10.1111/add.13214
- By:
- Publication type:
- Article
30
Temporal changes in alcohol-related mortality and morbidity in Australia.
- Published in:
- Addiction, 2016, v. 111, n. 4, p. 626, doi. 10.1111/add.13213
- By:
- Publication type:
- Article
31
Qualitative evaluation of a novel contingency management-related intervention for patients receiving supervised injectable opioid treatment.
- Published in:
- Addiction, 2016, v. 111, n. 4, p. 665, doi. 10.1111/add.13212
- By:
- Publication type:
- Article
32
Clinical provision of improvised nasal naloxone without experimental testing and without regulatory approval: imaginative shortcut or dangerous bypass of essential safety procedures?
- Published in:
- Addiction, 2016, v. 111, n. 4, p. 574, doi. 10.1111/add.13209
- By:
- Publication type:
- Article
33
LIQUOR LICENSING OR CONFOUNDING EVENTS? FURTHER QUESTIONS ABOUT THE INTERPRETATIONS OF MENÉNDEZ ET AL. (2015).
- Published in:
- 2016
- By:
- Publication type:
- Letter to the Editor
34
Gambling and gambling policy in Norway--an exceptional case.
- Published in:
- Addiction, 2016, v. 111, n. 4, p. 593, doi. 10.1111/add.13172
- By:
- Publication type:
- Article
35
The Brazilian 'Cracolândia' open drug scene and the challenge of implementing a comprehensive and effective drug policy.
- Published in:
- Addiction, 2016, v. 111, n. 4, p. 571, doi. 10.1111/add.13151
- By:
- Publication type:
- Article